Skip to main content
Behnam Badie, MD, Neurosurgery, Arcadia, CA

BehnamBadieMD

Neurosurgery • Arcadia, CA

Physician

Join to view full profile

Dr. Badie is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Badie's full profile

Already have an account?

  • Office

    301 W Huntington Dr
    Ste 400
    Arcadia, CA 91007
    Phone+1 626-574-3657
    Fax+1 626-218-5310

Education & Training

  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1989

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1991 - 2026
  • WI State Medical License
    WI State Medical License 1996 - 2007
  • Neurological Surgery
    American Board of Neurological Surgery Neurological Surgery

Grant Support

  • Improving Glioma Immunotherapy Efficacy by Regulating Tumor InflammationBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2023–2028
  • Improving Glioma Immunotherapy Efficacy by Regulating Tumor InflammationBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2023–2028
  • Improving Glioma Immunotherapy Efficacy by Regulating Tumor InflammationBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2023–2028
  • Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of VulnerabilityBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2021–2026
  • Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of VulnerabilityBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2021–2026
  • Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of VulnerabilityBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2021–2026
  • Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of GlioblastomaBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2020–2025
  • Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant gliomaBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2019–2025

Dr. Behnam Badie, Dr. Behnam Badie, MD, Dr. B Badie